← Back to home
· Corrected

AstraZeneca Stomach Cancer Drug Extends Survival in Late-Stage Trial but Misses Second Goal

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

An experimental AstraZeneca drug extended survival for patients with advanced…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

Updates

Correction, : Correction: The side-effect percentages refer to grade 3 or higher treatment-related adverse events, not the separate category of serious adverse events.
About this story

This story includes a public correction.

How NewsPlain works
← Back to home